CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 92 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $649,000 | +29.0% | 51,348 | +0.3% | 0.00% | – |
Q3 2020 | $503,000 | +269.9% | 51,207 | +351.2% | 0.00% | – |
Q2 2019 | $136,000 | +9.7% | 11,349 | +10.6% | 0.00% | – |
Q1 2019 | $124,000 | -12.7% | 10,260 | -9.1% | 0.00% | – |
Q4 2018 | $142,000 | -77.0% | 11,288 | -72.9% | 0.00% | -100.0% |
Q3 2018 | $618,000 | -56.0% | 41,668 | -50.1% | 0.00% | 0.0% |
Q2 2018 | $1,405,000 | -29.2% | 83,490 | -3.7% | 0.00% | -50.0% |
Q1 2018 | $1,985,000 | +168.6% | 86,671 | +203.4% | 0.00% | +100.0% |
Q4 2017 | $739,000 | +370.7% | 28,563 | +169.1% | 0.00% | – |
Q3 2017 | $157,000 | – | 10,616 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |